For the first time, researchers are reporting that a treatment might help stabilise Alzheimer’s disease for as much as three years, although the evidence is weak and in only four patients.

INTERNATIONAL healthcare giant Johnson & Johnson (J&J) formally became a significant shareholder in Irish pharmaceutical firm Elan yesterday as its amended equity investment deal was finally completed.